Evaluating the Efficacy of Channa Striata in Stabilizing eNOS in Patients With Septic.

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Sepsis
Interventions
DIETARY_SUPPLEMENT

Albumin Channa Striata Extract

This study is a randomized controlled trial of 42 patients at the ICU of Dr. Moewardi General Hospital. The control group received 20 grams of human albumin on the first day and the study group received 15 grams of Channa striata extract daily for two days. Subsequently, eNOS, NLR and PLR are measured before and three days after treatment, and the examiners compare the three markers statistically.

Trial Locations (1)

57126

Moewardi General Hospital, Sukoharjo

All Listed Sponsors
lead

Universitas Sebelas Maret

OTHER